Unlike lymphoid malignancies, where MYC overexpression is mostly associated with its translocation, the cause of MYC aberrant expression and activity in myeloid malignancies is not thoroughly established [29, 608]. The gene discussed is MYC; the disease is myeloid neoplasm.